Posard Matthew L. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$225,505.00
Insider Sells Quantity
10
Insider Sells Sum
$5.27M

Insider Activity of Posard Matthew L.

According to the SEC Form 4 filings, Posard Matthew L., being in a position of

  1. director at Halozyme Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24226 shares for $2.61M,
    over all time since 2022-12-02, has bought 0 shares, and sold 104107 shares for $7.02M.

Biography of Posard Matthew L.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,614,2422100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleHalozyme Therapeutics, Inc.
HALO
director
5,230
0.0045%
$108.54$567,661+14.55%
2026-09-16SaleHalozyme Therapeutics, Inc.
HALO
director
18,996
0.0159%
$107.74$2.05M+5.6%
2024-08-14SaleHalozyme Therapeutics, Inc.
HALO
director
9,881
0.0081%
$57.70$570,134-0.17%
2024-08-13SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$56.19$561,930+2.36%
2024-08-12SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$55.72$557,230+2.13%
2024-06-12SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.008%
$50.62$506,190+12.45%
2024-06-11SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$50.01$500,110+11.87%
2022-12-06SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0073%
$56.12$561,180-30.56%
2022-12-05SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0073%
$55.74$557,370-30.01%
2022-12-02SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0072%
$58.80$588,000-34.14%
2021-12-01PurchaseNautilus Biotechnology, Inc.
NAUT
director
30,000
0.0357%
$4.47$134,105-22.47%
2021-11-30PurchaseNautilus Biotechnology, Inc.
NAUT
director
20,000
0.0223%
$4.57$91,400-28.35%
2013-05-30SaleIllumina, Inc.
ILMN
Sr VP & General Manager
2,836
0.0023%
$70.80$200,789+37.33%
2013-04-11SaleIllumina, Inc.
ILMN
Sr VP & General Manager
11,550
0.0093%
$57.95$669,323+41.89%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.